Zealand Pharma Statistics

Total Valuation

Zealand Pharma has a market cap or net worth of DKK 24.21 billion. The enterprise value is 16.06 billion.

Market Cap	24.21B
Enterprise Value	16.06B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Zealand Pharma has 70.99 million shares outstanding. The number of shares has increased by 18.37% in one year.

Current Share Class	70.99M
Shares Outstanding	70.99M
Shares Change (YoY)	+18.37%
Shares Change (QoQ)	+1.58%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	50.62%
Float	60.49M

Valuation Ratios

The trailing PE ratio is 3.64 and the forward PE ratio is 3.95.

PE Ratio	3.64
Forward PE	3.95
PS Ratio	2.66
PB Ratio	1.55
P/TBV Ratio	1.55
P/FCF Ratio	3.22
P/OCF Ratio	3.21
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.23, with an EV/FCF ratio of 2.13.

EV / Earnings	2.40
EV / Sales	1.76
EV / EBITDA	2.23
EV / EBIT	2.24
EV / FCF	2.13

Financial Position

The company has a current ratio of 15.09, with a Debt / Equity ratio of 0.03.

Current Ratio	15.09
Quick Ratio	15.08
Debt / Equity	0.03
Debt / EBITDA	0.06
Debt / FCF	0.05
Interest Coverage	25.64

Financial Efficiency

Return on equity (ROE) is 53.44% and return on invested capital (ROIC) is 34.83%.

Return on Equity (ROE)	53.44%
Return on Assets (ROA)	32.86%
Return on Invested Capital (ROIC)	34.83%
Return on Capital Employed (ROCE)	44.76%
Revenue Per Employee	23.66M
Profits Per Employee	17.35M
Employee Count	335
Asset Turnover	0.67
Inventory Turnover	n/a

Taxes

In the past 12 months, Zealand Pharma has paid 534.00 million in taxes.

Income Tax	534.00M
Effective Tax Rate	7.40%

Stock Price Statistics

The stock price has decreased by -61.52% in the last 52 weeks. The beta is 0.55, so Zealand Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-61.52%
50-Day Moving Average	372.73
200-Day Moving Average	572.08
Relative Strength Index (RSI)	49.79
Average Volume (20 Days)	369,217

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Zealand Pharma had revenue of DKK 9.11 billion and earned 6.68 billion in profits. Earnings per share was 93.68.

Revenue	9.11B
Gross Profit	9.12B
Operating Income	7.19B
Pretax Income	7.21B
Net Income	6.68B
EBITDA	7.19B
EBIT	7.19B
Earnings Per Share (EPS)	93.68

Full Income Statement

Balance Sheet

The company has 16.58 billion in cash and 396.95 million in debt, giving a net cash position of 16.18 billion or 227.95 per share.

Cash & Cash Equivalents	16.58B
Total Debt	396.95M
Net Cash	16.18B
Net Cash Per Share	227.95
Equity (Book Value)	15.61B
Book Value Per Share	220.68
Working Capital	15.89B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.54 billion and capital expenditures -14.31 million, giving a free cash flow of 7.53 billion.

Operating Cash Flow	7.54B
Capital Expenditures	-14.31M
Free Cash Flow	7.53B
FCF Per Share	106.05

Full Cash Flow Statement

Margins

Gross margin is 100.06%, with operating and profit margins of 78.88% and 73.34%.

Gross Margin	100.06%
Operating Margin	78.88%
Pretax Margin	79.20%
Profit Margin	73.34%
EBITDA Margin	78.98%
EBIT Margin	78.88%
FCF Margin	82.64%

Dividends & Yields

Zealand Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.37%
Shareholder Yield	n/a
Earnings Yield	27.59%
FCF Yield	31.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6